WNT5A encodes two isoforms with distinct functions in cancers

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Bauer, Matthieu ^a,b   Bénard, Jean ^a,c   Gaasterland, Terry ^d   Willert, Karl ^b   Cappellen, David ^a,e,f  

^a CNRS   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84894125075     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080526     Document Type: Article

References (56)

1. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y et al. (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382: 225-230. doi:10.1038/382225a0. PubMed: 8717036.
2. Oishi I, Suzuki H, Onishi N, Takada R, Kani S et al. (2003) The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8: 645-654. doi:10.1046/j.1365-2443.2003.00662.x. PubMed: 12839624. (Pubitemid 36880848)
3. Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLOS Biol 4: e115. doi:10.1371/journal.pbio.0040115. PubMed: 16602827.
4. Yoshikawa S, McKinnon RD, Kokel M, Thomas JB (2003) Wnt-mediated axon guidance via the Drosophila Derailed receptor. Nature 422: 583-588. doi:10.1038/nature01522. PubMed: 12660735. (Pubitemid 36460405)
5. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407: 535-538. doi:10.1038/35035124. PubMed: 11029008.
6. Tamai K, Semenov M, Kato Y, Spokony R, Liu C et al. (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530-535. doi:10.1038/35035117. PubMed: 11029007.
7. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480. doi:10.1016/j.cell.2006.10.018. PubMed: 17081971.
8. van Amerongen R, Nusse R (2009) Towards an integrated view of Wnt signaling in development. Development 136: 3205-3214. doi:10.1242/dev.033910. PubMed: 19736321.
9. Klaus A, Birchmeier W (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387-398. doi:10.1038/nrc2389. PubMed: 18432252. (Pubitemid 351589714)
10. Network TCGA (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337. doi:10.1038/nature11252. PubMed: 22810696. doi:10.1038/nature11252 PubMed: 22810696
11. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540. doi:10.1038/35020115. PubMed: 10952317. (Pubitemid 30625740)
12. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P et al. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288. doi:10.1016/S1535-6108(02)00045-4. PubMed: 12086864. (Pubitemid 41039152)
13. Da Forno PD, Pringle JH, Hutchinson P, Osborn J, Huang Q et al. (2008) WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 14: 5825-5832. doi: 10.1158/1078-0432.CCR-07-5104. PubMed: 18794093.
14. O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP et al. (2009) The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 29: 34-44. doi:10.1038/onc.2009.305. PubMed: 19802008.
15. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A et al. (2006) Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66: 10439-10448. doi:10.1158/0008-5472.CAN-06-2359. PubMed: 17079465. (Pubitemid 44799765)
16. Ripka S, König A, Buchholz M, Wagner M, Sipos B et al. (2007) WNT5A - target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28: 1178-1187. doi: 10.1093/carcin/bgl255. PubMed: 17227781. (Pubitemid 47062676)
17. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G et al. (2003) Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4: 349-360. doi:10.1016/S1535-6108(03)00268-X. PubMed: 14667502. (Pubitemid 37491096)
18. Dejmek J, Dejmek A, Säfholm A, Sjölander A, Andersson T (2005) Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 65: 9142-9146. doi:10.1158/0008- 5472.CAN-05-1710. PubMed: 16230369. (Pubitemid 41507974)
19. Ying J, Li H, Chen Y-W, Srivastava G, Gao Z et al. (2007) WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 110: 4130-4132. doi:10.1182/blood-2007-06- 094870. PubMed: 18024799. (Pubitemid 350248475)
20. Ying J, Li H, Yu J, Ng KM, Poon FF et al. (2008) WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 14: 55-61. doi:10.1158/1078-0432.CCR-07-1644. PubMed: 18172252. (Pubitemid 351377978)
21. Dejmek J, Säfholm A, Kamp Nielsen C, Andersson T, Leandersson K (2006) Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42- casein kinase 1alpha signaling in human mammary epithelial cells. Mol Cell Biol 26: 6024-6036. doi:10.1128/MCB.02354-05. PubMed: 16880514. (Pubitemid 44204522)
22. Medrek C, Landberg G, Andersson T, Leandersson K (2009) Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells. J Biol Chem 284: 10968-10979. doi:10.1074/jbc.M804923200. PubMed: 19244247.
23. Jönsson M, Dejmek J, Bendahl P-O, Andersson T (2002) Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res 62: 409-416. PubMed: 11809689. (Pubitemid 34106413)
24. Cappellen D, Schlange T, Bauer M, Maurer F, Hynes NE (2007) Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep 8: 70-76. doi:10.1038/sj.embor.7400849. PubMed: 17159920. (Pubitemid 46043803)
25. Nishita M, Yoo SK, Nomachi A, Kani S, Sougawa N et al. (2006) Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 175: 555-562. doi:10.1083/jcb. 200607127. PubMed: 17101698. (Pubitemid 44790609)
26. Schambony A, Wedlich D (2007) Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev Cell 12: 779-792. doi:10.1016/j.devcel.2007.02.016. PubMed: 17488628. (Pubitemid 46667742)
27. He F, Xiong W, Yu X, Espinoza-Lewis R, Liu C et al. (2008) Wnt5a regulates directional cell migration and cell proliferation via Ror2- mediated noncanonical pathway in mammalian palate development. Development 135: 3871-3879. doi:10.1242/dev.025767. PubMed: 18948417.
28. Yamaguchi TP, Bradley A, McMahon AP, Jones S (1999) A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126: 1211-1223. PubMed: 10021340. (Pubitemid 29182117)
29. Danielson KG, Pillarisetti J, Cohen IR, Sholehvar B, Huebner K et al. (1995) Characterization of the complete genomic structure of the human WNT-5A gene, functional analysis of its promoter, chromosomal mapping, and expression in early human embryogenesis. J Biol Chem 270: 31225-31234. doi:10.1074/jbc.270. 52.31225. PubMed: 8537388. (Pubitemid 26012209)
30. Green JL, Bauer M, Yum KW, Li Y-C, Cox ML et al. (2013) Use of a molecular genetic platform technology to produce human Wnt proteins reveals distinct local and distal signaling abilities. PLOS ONE 8: e58395. doi:10.1371/journal.pone.0058395. PubMed: 23516471.
31. Willert KH, Brown JD, Danenberg E, Duncan AW, Weissman IL et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452. doi:10.1038/nature01611. PubMed: 12717451. (Pubitemid 36626997)
32. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S et al. (2006) Monounsaturated Fatty Acid Modification of Wnt Protein: Its Role in Wnt Secretion. Dev Cell 11: 791-801. doi:10.1016/j.devcel.2006.10.003. PubMed: 17141155. (Pubitemid 44804277)
33. Herr P, Basler K (2012) Porcupine-mediated lipidation is required for Wnt recognition by Wls. Dev Biol 361: 392-402. doi:10.1016/j.ydbio.2011.11.003. PubMed: 22108505.
34. Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC (2012) Structural Basis of Wnt Recognition by Frizzled. Science 337: 59-64. doi:10.1126/science. 1222879. PubMed: 22653731.
35. Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT (2003) Zebrafish Prickle, a Modulator of Noncanonical Wnt/Fz Signaling, Regulates Gastrulation Movements. Curr Biol 13: 680-685. doi: 10.1016/S0960-9822(03)00240-9. PubMed: 12699626. (Pubitemid 36453318)
36. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787. doi:10.1126/science.275.5307.1784. PubMed: 9065401. (Pubitemid 27136714)
37. González-Sancho JM, Brennan KR, Castelo-Soccio LA, Brown AMC (2004) Wnt proteins induce dishevelled phosphorylation via an LRP5/6-independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol Cell Biol 24: 4757-4768. doi:10.1128/MCB.24.11.4757-4768.2004. PubMed: 15143170. (Pubitemid 38668042)
38. Willert KH, Brink M, Wodarz A, Varmus H, Nusse R (1997) Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J 16: 3089-3096. doi:10.1093/emboj/16.11.3089. PubMed: 9214626. (Pubitemid 27234948)
39. Yanagawa S, van Leeuwen F, Wodarz A, Klingensmith J, Nusse R (1995) The dishevelled protein is modified by wingless signaling in Drosophila. Genes Dev 9: 1087-1097. doi:10.1101/gad.9.9.1087. PubMed: 7744250.
40. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ et al. (2008) CDK8 is a colorectal cancer oncogene that regulates β-catenin activity. Nature 455: 547-551. doi:10.1038/nature07179. PubMed: 18794900.
41. Morris EJ, Ji J-Y, Yang F, Di Stefano L, Herr A et al. (2008) E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8. Nature 455: 552-556. doi:10.1038/nature07310. PubMed: 18794899.
42. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369: 2106-2120. doi:10.1016/S0140-6736(07)60983-0. PubMed: 17586306. (Pubitemid 46935947)
43. Katula KS, Joyner-Powell NB, Hsu C-C, Kuk A (2012) Differential Regulation of the Mouse and Human Wnt5aAlternative Promoters A and B. DNA Cell Biol 31: 1585-1597. doi:10.1089/dna.2012.1698. PubMed: 23046419.
44. Fear MW, Kelsell DP, Spurr NK, Barnes MR (2000) Wnt-16a, a Novel Wnt-16 Isoform, Which Shows Differential Expression in Adult Human Tissues. Biochem Biophys Res Commun 278: 814-820. doi:10.1006/bbrc.2000.3852. PubMed: 11095990.
45. Bunaciu RP, Tang T, Mao CD (2008) Differential expression of Wnt13 isoforms during leukemic cell differentiation. Oncol Rep 20: 195-201. PubMed: 18575737.
46. Teh M-T, Blaydon D, Ghali LR, Briggs V, Edmunds S et al. (2007) Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J Cell Sci 120: 330-339. doi:10.1242/jcs.03329. PubMed: 17200136.
47. Moon RT, Campbell RM, Christian JL, McGrew LL, Shih J et al. (1993) Xwnt-5A: a maternal Wnt that affects morphogenetic movements after overexpression in embryos of Xenopus laevis. Development 119: 97-111. PubMed: 8275867. (Pubitemid 23279130)
48. Torres MA, Yang-Snyder JA, Purcell SM, DeMarais AA, McGrew LL et al. (1996) Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J Cell Biol 133: 1123-1137. doi: 10.1083/jcb.133.5.1123. PubMed: 8655584. (Pubitemid 26172516)
49. Qian D, Jones C, Rzadzinska A, Mark S, Zhang X et al. (2007) Wnt5a functions in planar cell polarity regulation in mice. Dev Biol 306: 121-133. doi:10.1016/j.ydbio.2007.03.011. PubMed: 17433286. (Pubitemid 46823929)
50. Cha S-W, Tadjuidje E, Tao Q, Wylie C, Heasman J (2008) Wnt5a and Wnt11 interact in a maternal Dkk1-regulated fashion to activate both canonical and non-canonical signaling in Xenopus axis formation. Development 135: 3719-3729. doi:10.1242/dev.029025. PubMed: 18927149.
51. Fuerer C, Nusse R (2010) Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLOS ONE 5: e9370. doi:10.1371/journal.pone.0009370. PubMed: 20186325.
52. Ferrandis E, Da Silva J, Riou G, Bénard I (1994) Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res 54: 2256-2261. PubMed: 8174136. (Pubitemid 24138705)
53. Meier R, Mühlethaler-Mottet A, Flahaut M, Coulon A, Fusco C et al. (2007) The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumor and metastatic growth, but not invasion. PLOS ONE 2: e1016. doi:10.1371/journal.pone.0001016. PubMed: 17925864.
54. Kemshead JT, Ritter MA, Cotmore SF, Greaves MF (1982) Human Thy-1: expression on the cell surface of neuronal and glial cells. Brain Res 236: 451-461. doi:10.1016/0006-8993(82)90727-2. PubMed: 6121610. (Pubitemid 12132564)
55. Goillot E, Combaret V, Ladenstein R, Baubet D, Blay JY et al. (1992) Tumor necrosis factor as an autocrine growth factor for neuroblastoma. Cancer Res 52: 3194-3200. PubMed: 1317260.
56. Willert KH (2008) Isolation and application of bioactive Wnt proteins. In: E Vincan. Wnt Signaling. Melbourne: Methods in molecular biology (Clifton, N.J.), Vol. 468. pp. 17-29. doi:10.1007/978-1-59745-249-6-2 PubMed: 19099243